HUTCHMED (China) (HCM) Current Deferred Revenue (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Current Deferred Revenue for 10 consecutive years, with $31.4 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 37.26% to $31.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.4 million through Dec 2025, down 37.26% year-over-year, with the annual reading at $31.4 million for FY2025, 37.26% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $31.4 million at HUTCHMED (China), down from $50.1 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $57.6 million in Q4 2023, with the low at $13.3 million in Q4 2022.
  • Average Current Deferred Revenue over 4 years is $38.1 million, with a median of $40.7 million recorded in 2024.
  • The sharpest move saw Current Deferred Revenue skyrocketed 331.85% in 2023, then plummeted 37.26% in 2025.
  • Over 4 years, Current Deferred Revenue stood at $13.3 million in 2022, then surged by 331.85% to $57.6 million in 2023, then decreased by 13.13% to $50.1 million in 2024, then plummeted by 37.26% to $31.4 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $31.4 million, $50.1 million, and $57.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.